🔎 Trials Near Me

Beranda › Skleroderma › Arizona

Uji klinis Skleroderma di Arizona

6 studi untuk Skleroderma mencari peserta di lokasi di Arizona.

Kota di Arizona

Teks studi resmi (Bahasa Inggris)

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  • Banner - University Medicine Rheumatology Clinic, Phoenix
  • Arizona Arthritis and Rheumatology Associates - Paradise Valley, Scottsdale
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  • Arizona Arthritis and Rheumatology Associates, Phoenix
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06655155

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Phoenix
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05878717

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Phoenix, Phoenix
  • Artiva Investigational Site Tucson, Tucson
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06991114

A Study of AZD0120 in Autoimmune Diseases

  • Research Site, Tucson
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07295847

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.